“We did not set out to build another health insurance company,” said Ty Wang, co-founder and chief executive of Angle Health. The aim, he told the Wall Street Journal, was to stop “this kind of death spiral of cost within our healthcare system.” His company has just raised $600m at a $2.7bn valuation. Vitruvian Partners […]This story continues at The Next Web